CD8A and neoplasm: To further measure the tumor, stroma, and immune cell components in PDAC tumor tissues, a workflow was established and optimized for mIHC to assess three markers (CD8, PD-1, PanCK) to simultaneously depict cell subtypes with single or multiple markers (Figure 4A).